B2B: Bladder Cancer Summary
The 7th Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting, organized in conjunction with the 45th Annual Congress of the Société Internationale d’Urologie, was held on 31 October 2025, in Edinburgh, Scotland, and transmitted live on the SIU@U Congress app [...]
Authors
- Param Mariappan
- Stephen J. Williams (ORCID: https://orcid.org/0000-0001-8848-6372)
- Daniele Raggi (ORCID: https://orcid.org/0000-0002-4185-2475)
- R. Jones
- Kilian M. Gust
- V. Grünwald
- Jeremy Y. C. Teoh
- Peter C. Black
- Karima Oualla
Institutions
- Royal Marsden NHS Foundation Trust (GB)
- University of British Columbia (CA)
- Chinese University of Hong Kong (HK)
- Western General Hospital (GB)
- Beatson West of Scotland Cancer Centre (GB)
- Edinburgh Cancer Research (GB)
- Comprehensive Cancer Center Vienna (AT)
- Essen University Hospital (DE)
- The University of Texas Medical Branch at Galveston (US)
- Medical University of Vienna (AT)
- Sidi Mohamed Ben Abdellah University (MA)
Publication Details
- Journal
- Société Internationale d’Urologie Journal
- Published
- 2026-02-09
- DOI
- https://doi.org/10.3390/siuj7010005
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- AstraZeneca
- Novartis Pharma
- Daiichi Sankyo Europe